Report on the latest developments in Bruton's tyrosine kinase inhibition (BTKi) and B-cell lymphoma 2 inhibition (BCL2i) in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and other B-cell malignancies presented at ASH 2021.
Welcome to BeiMedPlus
BeiGene's medical website with resources for healthcare professionals and disease information for patients and caregivers.
Please confirm the option below that best describes you so we can direct you to appropriate resources and information.
I am a...
Healthcare Professional
hcp
Patient / Caregiver
patient
BeiGene Employee
employee
I am from...
GLOBAL (ex-US) / EN
/
GLOBAL (ex-US) / EN
pts-en
France / FR
fr
Germany / DE
de
Italy / IT
it
Italy / IT
pts-it
Spain / ES
es
Sweden / SE
se
Switzerland / DE
ch-de
Switzerland / FR
ch-fr
Switzerland / IT
ch-it
United States / EN
us
